IFF stock was upgraded to a Buy rating on January 25, 2022, by Stifel.
IFF upgraded to Buy from Hold at Stifel
On January 25, 2022, Stifel analyst Mark Astrachan upgraded IFF (IFF) to Buy from Hold with a price target of $160, up from $155. The analyst sees the company’s sales growth ahead of its peers for the first time since Q2 of 2021 and continuing during 2022. IFF’s recent appointment of Frank Clyburn as CEO – a former Merck (MRK) executive with P&L responsibility for about 90% of company sales – should also help to improve consistency of currency-neutral sales growth, Astrachan tells investors in a research note.
IFF rallies after CNBC says Icahn has 4% stake
On January 20, 2022, CNBC said Carl Icahn owns a 4% stake in IFF. The stock has caught a lions-share of bids following the report. Source: https://www.cnbc.com/2022/01/20/carl-icahn-owns-4percent-stake-in-international-flavors-fragrances-sources-say.html
IFF initiated with a Buy at Jefferies
On January 13, 2022, Jefferies analyst Laurence Alexander initiated coverage of IFF with a Buy rating and $180 price target, which represents 23% upside. Last year’s merger with DuPont’s N&B business made IFF a “global leader in ingredients and solutions” and he expects the valuation gap to peers to narrow as IFF closes the organic growth rate gap, Alexander said. Cost synergies that lead to margin expansion and deleveraging through asset sale should also support multiple expansion, added the analyst.
IFF and SleepScore Labs to Unveil Validated Scent Solutions to Support Improved Sleep at CES 2022
On January 3, 2022, IFF (NYSE: IFF) and SleepScore Labs introduced a groundbreaking scent solution to improve sleep quality, building on the partnership initiated in 2020 and leveraging IFF’s internal Science of Wellness program. The two companies will be demonstrating the new solution at the CES 2022 in Las Vegas – a scent that showed sleep improvement on an objective level in a SleepScore Labs study, including faster time to fall asleep, less time spent awake during the night, longer sleep duration, and improved sleep efficiency.
“IFF has always been a pioneer when it comes to creating scent solutions to improve people’s lives”, says Christophe de Villeplée, IFF’s Scent Division President. “The two first years of our partnership with SleepScore Labs were used by our perfumers and innovation teams to develop scents using our data science and SleepScore Labs biometric measures to improve sleep quality. The CES show will allow tech-savvy visitors to discover our unique scent wellness solution and experience it firsthand”.
With 70% of the developed world impacted by poor sleep and the resulting adverse effects on overall health, the need to develop data-driven solutions is a call to action. IFF, an industry leader in food, beverage, scent, health and biosciences, and SleepScore Labs, the company behind a comprehensive suite of data-backed sleep solutions, leverage their combined expertise with a science-based, biometrically measured scent solution to support improved sleep.
The two organizations have collaborated to produce in-context biometrically tested scents. The studies utilize SleepScore’s non-contact measurement technology to extract respiratory signal and body movements, to not only determine sleep-wake cycles but also specific sleep stages, including Light, Deep, and REM. Their technology has been validated using polysomnography (PSG), the gold standard for objective sleep measurement.
”Billions of people are constantly searching for solutions to help them sleep better but most consumer solutions have little or no hard scientific data on their performance,” said Colin Lawlor, CEO of SleepScore Labs. “We are tremendously proud to work with IFF in leveraging the best data and science to bring real products which can be easily used in homes around the world to help people truly sleep better. Duly tested.”
IFF business unit receives European Commission approval for Enviva Pro
On December 13, 2021, Danisco Animal Nutrition, a business unit of IFF, announced the final authorization from the European Commission to expand the use of Enviva Pro, a multi-strain probiotic, to the European turkey production market. This development is the next step in Danisco Animal Nutrition’s continuing commitment to support the food solution needs of the poultry industry.
📺 International Flavors & Fragrances CEO: Making Cents From Scents | Mad Money | CNBC
📉 IFF Stock Technical Analysis
The long-term trend is neutral, but the short-term trend is negative. IFF is an average performer in the Chemicals industry, it outperforms 52% of 121 stocks in the same industry. IFF is currently trading in the middle of its 52-week range. This is in line with the S&P500 Index, which is also trading in the middle of its range. Volume is considerably higher in the last couple of days.
There is a support zone ranging from 131.58 to 132.63. This zone is formed by a combination of multiple trend lines in multiple time frames.
There is resistance at 135.29 from a horizontal line in the daily time frame. There is a resistance zone ranging from 141.55 to 146.51. This zone is formed by a combination of multiple trend lines and important moving averages in multiple time frames. There is also a resistance zone ranging from 151.83 to 153.13. This zone is formed by a combination of multiple trend lines in multiple time frames.
IFF has a poor technical rating and the quality of the setup is also not perfect at the moment. IFF stock has a Setup Rating of 4 out of 10. Price movement has been a little bit too volatile to find a nice entry and exit point. It is probably a good idea to wait for a consolidation first. Click here to sign up for email alerts on when IFF stock consolidates and has a Setup Rating of 8 or higher.